Increasing Breast and Colorectal Cancer Screening in the Community

Conditions

• Breast Neoplasms
• Colorectal Neoplasms

Eligibility Criteria

Sex

FEMALE

Age

45 Years - 75 Years

Healthy Volunteers

Accepted

Interventions

• Chi gung: Stay Well, Live Well — BEHAVIORAL
  The intervention consists of a A) 90-minute group education session led by a community health worker (CHW) that 1) addresses CRC and BC incidence, mortality, development, symptoms, and screening tests, in addition to shared beliefs and common obstacles to CRC and BC screening, 2) involves experiential education (e.g., demonstrations of stool based testing and colonoscopy bowel preparation), 3) question and answer session, and 4) take-home materials summarizing CRC and BC screening information and local resources; and B) peer navigation assistance by telephone to address ongoing obstacles to CRC and BC screening completion, conducted over a 6 month period.
• Chi gung: Stay Well, Live Well — BEHAVIORAL
  The attention control arm will receive a A) time-matched (90-minute) general health didactic on risk factors for cancer and take-home materials on concepts discussed, and B) telephone calls to address concepts covered in the presentation (number of calls will be based on the average frequency of peer navigation calls in the intervention arm).

Study Details

The goal of the proposed study is to conduct a pilot randomized controlled trial (RCT) of Chi gung, a community-based intervention using peer education and tailored navigation to simultaneously improve colorectal (CRC) and breast cancer (BC) screening rates.

Key Dates

First listed

Aug 5, 2026

Start date

Sep 30, 2026

Status verified

Jul 2026

Primary completion

Dec 31, 2028

Completion

Mar 31, 2029

Study Design

Enrollment

80 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Arms

• Experimental: Chi gung: Stay Well, Live Well
  Chi gung: Stay Well, Live Well is a community-based intervention using peer education and tailored navigation
• Active Comparator: Attention Control (AC) Arm
  This time-matched and attention control group will receive a general health group education session and follow-up telephone calls.

Primary Outcome Measure

Intervention Acceptability Score [ Time Frame: 6 Months ]

Central Contacts

• Christina Wang, MD
  216-702-0789
  [email protected]
• Lili Liang
  347-270-7705
  [email protected]

Locations (7)

Find similar trials in New York, NY

Related Studies

• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
  PHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
• A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
  PHASE2 · Recruiting · GlaxoSmithKline · Encinitas, California
• Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
  Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
  PHASE3 · Recruiting · Seagen, a wholly owned subsidiary of Pfizer · Glendale, Arizona